Compare NTHI & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTHI | ACR |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.5M | 169.2M |
| IPO Year | N/A | N/A |
| Metric | NTHI | ACR |
|---|---|---|
| Price | $8.31 | $20.19 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $24.50 |
| AVG Volume (30 Days) | ★ 66.3K | 34.1K |
| Earning Date | 02-19-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.65 |
| EPS | N/A | ★ 0.95 |
| Revenue | $59,990.00 | ★ $88,952,000.00 |
| Revenue This Year | N/A | $3.67 |
| Revenue Next Year | N/A | $1.87 |
| P/E Ratio | ★ N/A | $21.30 |
| Revenue Growth | N/A | ★ 14.87 |
| 52 Week Low | $3.20 | $15.64 |
| 52 Week High | $25.00 | $24.61 |
| Indicator | NTHI | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 44.20 | 38.53 |
| Support Level | $8.11 | $19.94 |
| Resistance Level | $10.19 | $20.84 |
| Average True Range (ATR) | 0.86 | 0.49 |
| MACD | -0.04 | -0.06 |
| Stochastic Oscillator | 12.92 | 20.15 |
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.